Jihyun An

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

Metastatic Colorectal Cancer

Ejection Fraction

Liver Metastases

Top Venues

Journal of liver cancer

Hepatology (Baltimore, Md.)

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Myung Han Hyun, Ji Hoon Kim, Jeong Won Jang, Jeong Eun Song, Do Seon Song, Hye Won Lee, Young Youn Cho, Gi-Ae Kim, Eileen L Yoon, Dong Hyun Sinn, Soon Sun Kim, Sun Young Yim, Hyun Yang, Jihyun An
Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 82 (3) (2023)
Jihyun An, Ju Hyun Shim
Is ageing a problematic hurdle to the efficacy of first-line atezolizumab plus bevacizumab in hepatocellular carcinoma? Liver international : official journal of the International Association for the Study of the Liver 42 (11) (2022)
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. Journal of liver cancer 22 (1) (2022)
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. Journal of liver cancer 22 (1) (2022)
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. Journal of liver cancer 22 (1) (2022)
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. Journal of liver cancer 22 (1) (2022)
Jihyun An, Seungbong Han, Ha Il Kim, Ju Hyun Shim
Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno-oncology: A network meta-analysis of randomized sorafenib-controlled trials. Hepatology communications 6 (10) (2022)
Jihyun An, Ji-Hye Oh, Bora Oh, Yoo-Jin Oh, Jin-Sung Ju, Wonkyung Kim, Hyo Jeong Kang, Chang Ohk Sung, Ju Hyun Shim
Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination-deficient hepatocellular carcinoma. Hepatology (Baltimore, Md.) (2022)
Jihye Lim, Jung-Bok Lee, Jihyun An, Gi-Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000-Korean outcome study. Journal of viral hepatitis 29 (9) (2022)
Jihyun An, Deokhoon Kim, Bora Oh, Yoo-Jin Oh, Jihyun Song, Naomi Park, Ha Il Kim, Hyo Jeong Kang, Ji-Hye Oh, Wonkyung Kim, Eunjung Lee, Chang Ohk Sung, Gi-Won Song, Dae-Ghon Kim, Eunsil Yu, Eric Letouzé, Jessica Zucman-Rossi, Han Chu Lee, Ju Hyun Shim
Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas. Hepatology (Baltimore, Md.) (2021)
Jihyun An, Ha Il Kim, Bora Oh, Yoo-Jin Oh, Ji-Hye Oh, Wonkyung Kim, Chang Ohk Sung, Ju Hyun Shim
Integrated prognostic and histogenomic justification of stage-directed therapy for single large hepatocellular carcinoma: a Korean nationwide registry study. Gut (2021)
Jihyun An
[Current Status and Future Directions of Hepatocellular Carcinoma Surveillance Test Based on Cost-effective Analysis]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 78 (5) (2021)
Jihyun An, Seheon Chang, Ha Il Kim, Gi-Won Song, Ju Hyun Shim
The clinical behavior and survival of patients with hepatocellular carcinoma and a family history of the disease. Cancer medicine 8 (15) (2019)
Jihyun An, Seong Kyun Na, Ju Hyun Shim, Yang Soon Park, Mi Jung Jun, Joo Ho Lee, Gi-Won Song, Hac Chu Lee, Eunsil Yu
Histological expression of methionine adenosyl transferase (MAT) 2A as a post-surgical prognostic surrogate in patients with hepatocellular carcinoma. Journal of surgical oncology 117 (5) (2018)